A federal ban on taxpayer dollars flowing to abortion providers is set to expire July 4 after being included in President Donald Trump's major legislative package last year, setting up a contentious debate over reproductive health funding as Congress returns to session.
The provision was part of the administration's sweeping budget reconciliation bill that barred federal Medicaid and Medicare funds from going to organizations that perform abortions. That ban expires next month unless Congress acts to extend it.
Sen. Josh Hawley, R-Mo., is pushing for increased oversight before the deadline lapses. In a letter to Centers for Medicare and Medicaid Services Administrator Mehmet Oz, Hawley requested an investigation into approximately $1.5 billion in federal funding that Planned Parenthood received between 2019 and 2022, according to a Government Accountability Office report published in November 2023.
What the Right Is Saying
Hawley's letter specifically called for investigating whether federal funds supported what he described as "transgender madness" procedures on minors, arguing it would be "unconscionable" for taxpayer money to flow toward gender-transition drugs and surgeries for children without parental knowledge.
"The organization openly advertises that it provides sex-change drugs and refers for transgender surgeries," Hawley wrote. He cited reports indicating a 40% year-over-year increase in what Planned Parenthood describes as "gender-affirming care."
Conservative lawmakers argue that federal healthcare programs should not fund procedures they consider experimental or harmful to minors, particularly without robust parental notification requirements. They contend that existing safeguards are insufficient and that the July lapse provides an opportunity to attach additional conditions.
Republican legislators have pushed for extending the funding ban through 2035, though an amendment to do so failed earlier this year during budget reconciliation negotiations. They maintain that blocking federal funds to abortion providers remains a priority regardless of other policy considerations.
What the Left Is Saying
Democratic lawmakers and reproductive health advocates argue that restricting Medicaid funding to Planned Parenthood does not reduce the need for healthcare services—it only limits where low-income patients can receive care. They note that Planned Parenthood provides cancer screenings, STI testing, contraception, and prenatal care that serve millions of Americans who otherwise lack access to affordable healthcare.
Progressive groups contend that Republican efforts to defund Planned Parenthood are part of a broader campaign targeting reproductive rights rather than addressing actual concerns about program integrity. They argue that existing federal auditing mechanisms already exist for Medicaid spending and that singling out one provider reflects political motivation over fiscal responsibility.
Healthcare policy advocates aligned with Democrats have pointed out that gender-affirming care for minors requires parental consent in most states and is subject to medical guidelines established by professional associations including the American Academy of Pediatrics. They argue that restricting coverage does not address underlying healthcare needs.
Planned Parenthood did not respond to requests for comment for this article.
What the Numbers Show
The Government Accountability Office report tracked approximately $1.5 billion in Medicaid and Medicare payments to Planned Parenthood between fiscal years 2019 and 2022, though the report did not specify how those funds were allocated across different services.
According to Hawley's letter, his proposed amendment would have extended the ban on providing Medicaid funding to abortion providers until 2035. The current provision expires July 4 unless Congress passes legislation to extend it.
Planned Parenthood serves approximately 2 million patients annually at more than 500 health centers nationwide, according to the organization's most recent public data. Federal funding represents a significant portion of its revenue, though the organization does not break down spending by procedure type in publicly available filings.
A 2023 Kaiser Family Foundation analysis found that Medicaid reimbursement accounts for roughly 40% of Planned Parenthood's total revenue, with the percentage varying by state depending on which services qualify for federal matching funds.
The Bottom Line
Congress faces a July 4 deadline to extend or allow lapses in provisions blocking certain federal healthcare funds from flowing to abortion providers. The timing puts pressure on lawmakers negotiating government funding bills this month.
Hawley's investigation request adds another layer to the debate, though any CMS review would need to comply with existing legal frameworks around patient privacy and program integrity audits. Whether Oz's administration pursues such an investigation remains to be seen.
What happens next: Congress must address government funding before fiscal year deadlines this fall. The Planned Parenthood funding ban is expected to be part of those negotiations, with both sides likely to use the July 4 deadline as leverage in broader discussions.